Ignite Creation Date:
2024-05-05 @ 5:00 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00367601
Status:
COMPLETED
Last Update Posted:
2016-02-11
First Post:
2006-08-21
Brief Title:
Erlotinib Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
Sponsor:
Organization:
Hoosier Cancer Research Network